Making Medical Supply Chains More Secure
How can we make global supply chains and manufacturing arrangements for pharmaceutical and medical products more dependable and resilient?
Please join the CSIS Scholl Chair in International Business, Congressman Adrian Smith, and representatives from Brazil, Canada, Colombia and Mexico on June 14 at 10:30 AM EDT, for a discussion on the challenges of medical supply chains in the wake of the Covid-19 pandemic. This conversation will be the capstone of a research effort that CSIS is undertaking to investigate how to make global supply chains and manufacturing arrangements for pharmaceutical and medical products more dependable and resilient. There is bipartisan consensus on Capitol Hill and in the Biden administration regarding excessive dependence on Chinese manufacturing and production. An extension of this is that diversification of supply chains for certain medical products will make U.S. citizens more secure in fighting future infectious diseases.
This event is made possible with the generous support of Pfizer Inc. and Gilead Sciences Inc.